Prediction: as the concentration of factor VIII increases, the clotting time decreases (until it levels off when factor VIII is no longer limiting).
Independent variable: make at least five concentrations of factor VIII by diluting the stock solution with buffer, e.g. 20%, 40%, 60%, 80% and 100% of the stock concentration (proportional dilution: 2, 4, 6, 8, 10 cm³ of stock made up to 10 cm³ with buffer).
Method: place 0.5 cm³ of factor-VIII-deficient plasma in a test-tube in a water bath at 37 °C for 5 minutes. Add 0.1 cm³ of the factor VIII solution, then 0.1 cm³ of activator and 0.1 cm³ of calcium chloride solution; start the stopwatch when the calcium chloride is added. Tilt the tube every 5 s and record the time at which the plasma no longer flows.
Dependent variable: clotting time in s.
Standardised variables: volume of plasma; volume of factor VIII solution; volume and concentration of activator and calcium chloride; temperature (37 °C water bath); same batch of plasma; same tilting interval and angle.
Controls: plasma with buffer instead of factor VIII (0% concentration) to show clotting time without factor VIII; normal plasma as a comparison.
Reliability: three replicates at each concentration; calculate the mean; discard anomalous results and repeat.
Risk: human plasma could contain pathogens — medium risk; wear gloves and eye protection, disinfect spills and dispose of plasma as biological waste.